Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: Two systematic reviews

Trials

Volumn 16, Issue 1, 2015, Pages

  Clyburne Sherin, April V P ^a   Thurairajah, Pravheen ^a   Kapadia, Mufiza Z ^a   Sampson, Margaret ^b   Chan, Winnie W Y ^a   Offringa, Martin ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

Clinical trials; CONSORT; CONSORT C; Protocols; Reporting; SPIRIT; SPIRIT C; Systematic review

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); EVIDENCE BASED MEDICINE; EXTERNAL VALIDITY; HUMAN; INTERNAL VALIDITY; QUALITY CONTROL; REPRODUCIBILITY; RESEARCH ETHICS; SENSITIVITY ANALYSIS; STUDY DESIGN; SYSTEMATIC REVIEW; INFORMATION PROCESSING; METHODOLOGY; PEDIATRICS; PRACTICE GUIDELINE; STANDARDS;

CLINICAL PROTOCOLS; CLINICAL TRIALS AS TOPIC; DATA COLLECTION; EVIDENCE-BASED MEDICINE; HUMANS; PEDIATRICS; PRACTICE GUIDELINES AS TOPIC; RESEARCH DESIGN;

EID: 84955340615     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-015-0954-0     Document Type: Article

References (165)

1. Saint-Raymond A, Hill S, Martines J, Bahl R, Fontaine O, Bero L. CONSORT 2010. The Lancet. 2010;376(9737):229-30.
2. Hartling L, Wittmeier KD, Caldwell P, van der Lee H, Klassen TP, Craig JC, et al. StaR child health: developing evidence-based guidance for the design, conduct, and reporting of pediatric trials. Pediatrics. 2012;129 Suppl 3:S112-7.
3. Gardner F, Mayo-Wilson E, Montgomery P, Hopewell S, Macdonald G, Moher D, et al. The need for new guidelines to improve the reporting of trials in child and adolescent mental health. J Child Psychol Psychiatry. 2013;54(7):810-2.
4. Moher D, Sampson M, Campbell K, Beckner W, Lepage L, Gaboury I, et al. Assessing the quality of reports of randomized trials in pediatric complementary and alternative medicine. BMC Pediatr. 2002;2:2. doi: 10.1186/1471-2431-2-2.
5. Dellinger RP, Vincent JL, Marshall J, Reinhart K. Important issues in the design and reporting of clinical trials in severe sepsis and acute lung injury. J Crit Care. 2008;23(4):493-9.
6. Frakking F, van der Lee J, Klassen T, Offringa M. Survey of current guidance for child health clinical trials. Standards for Research in Children: The StaR Child Health Project; 2011.
7. Dwan K, Altman DG, Arnaiz JA, Bloom J, Chan A-W, Cronin E, et al. Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One. 2008;3(8):e3081.
8. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152(11):726-32.
9. Blakely ML, Kao LS, Tsao K, Huang EY, Tsai A, Tanaka S, et al. Adherence of randomized trials within children's surgical specialties published during 2000 to 2009 to standard reporting guidelines. J Am Coll Surg. 2013;217(3):394-9.e7.
10. Al-Namankany AA, Ashley P, Moles DR, Parekh S. Assessment of the quality of reporting of randomized clinical trials in paediatric dentistry journals. Int J Paediatr Dent. 2009;19(5):318-24.
11. Thakur A, Wang EC, Chiu TT, Chen W, Ko CY, Chang JT, et al. Methodology standards associated with quality reporting in clinical studies in pediatric surgery journals. J Pediatr Surg. 2001;36(8):1160-4.
12. Anttila H, Malmivaara A, Kunz R, Autti-Ramo I, Makela M. Quality of reporting of randomized, controlled trials in cerebral palsy. Pediatrics. 2006;117(6):2222-30.
13. Dapuzzo L, Seitz FE, Dodson WC, Stetter C, Kunselman AR, Legro RS. Incomplete and inconsistent reporting of maternal and fetal outcomes in infertility treatment trials. Fertility & Sterility. 2011;95(8):2527-30.
14. Scott P, Ott F, Egger M, Low N. Completeness of reporting in randomized controlled trials of 3 vaccines: a review of adherence to the CONSORT checklist. Pediatr Infect Dis J. 2012;31(12):1286-94.
15. Ma B, Ke FY, Chen ZM, Qi GQ, Li HM, Liu WJ, et al. Does the reporting of randomized clinical trials published in Chinese pediatrics journals improve after the CONSORT Statement is adopted? Contemp Clin Trials. 2012;33(5):889-94.
16. Hamm MP, Hartling L, Milne A, Tjosvold L, Vandermeer B, Thomson D, et al. A descriptive analysis of a representative sample of pediatric randomized controlled trials published in 2007. BMC Pediatr. 2010;10:96.
17. Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Krebs Seida J, et al. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ. 2009;339.
18. de Vries TW, van Roon EN. Low quality of reporting adverse drug reactions in paediatric randomised controlled trials. Arch Dis Child. 2010;95(12):1023-6.
19. Robb SL, Carpenter JS. A review of music-based intervention reporting in pediatrics. J Health Psychol. 2009;14(4):490-501.
20. Crocetti MT, Amin DD, Scherer R. Assessment of risk of bias among pediatric randomized controlled trials. Pediatrics. 2010;126(2):298-305.
21. Walleser S, Hill SR, Bero LA. Characteristics and quality of reporting of cluster randomized trials in children: reporting needs improvement. J Clin Epidemiol. 2011;64(12):1331-40.
22. Fernandes RM, van der Lee JH, Offringa M. Data monitoring committees, interim analysis and early termination in paediatric trials. Acta Paediatr. 2011;100(10):1386-92.
23. Tetzlaff JM, Chan A-W, Kitchen J, Sampson M, Tricco AC, Moher D. Guidelines for randomized clinical trial protocol content: a systematic review. Syst Rev. 2012;1:43.
24. Chan A-W, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291(20):2457-65.
25. Pildal J, Chan A-W, Hróbjartsson A, Forfang E, Altman DG, Gøtzsche PC. Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study. BMJ. 2005;330(7499):1049.
26. Chan A-W, Hróbjartsson A, Jørgensen KJ, Gøtzsche PC, Altman DG. Discrepancies in sample size calculations and data analyses reported in randomised trials: comparison of publications with protocols. BMJ. 2008;337.
27. Gøtzsche PC, Hróbjartsson A, Johansen HK, Haahr MT, Altman DG, Chan A-W. Ghost authorship in industry-initiated randomised trials. PLoS Med. 2007;4(1):e19.
28. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200-7. doi: http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00583.
29. Sinha IP, Altman DG, Beresford MW, Boers M, Clarke M, Craig J, et al. Standard 5: selection, measurement, and reporting of outcomes in clinical trials in children. Pediatrics. 2012;129 Suppl 3:S146-52.
30. Amin SB, McDermott MP, Shamoo AE. Clinical trials of drugs used off-label in neonates: ethical issues and alternative study designs. Account Res. 2008;15(3):168-87.
31. Berde CB, Walco GA, Krane EJ, Anand KJ, Aranda JV, Craig KD, et al. Pediatric analgesic clinical trial designs, measures, and extrapolation: report of an FDA scientific workshop. Pediatrics. 2012;129(2):354-64.
32. Anonymous. European Union. Ethical considerations for clinical trials on medicinal products conducted with the paediatric population. Eur J Health Law. 2008;15(2):223-50.
33. Ward RM, Green TP. Developmental pharmacology and toxicology: principles of study design and problems of methodology. Pharmacol Ther. 1988;36(2-3):309-34.
34. Verhamme K, Sturkenboom M. Study designs in paediatric pharmacoepidemiology. Eur J Clin Pharmacol. 2011;67 Suppl 1:67-74.
35. Dumont C, Mentre F, Gaynor C, Brendel K, Gesson C, Chenel M. Optimal sampling times for a drug and its metabolite using SIMCYP() simulations as prior information. Clin Pharmacokinet. 2013;52(1):43-57. doi: http://dx.doi.org/10.1007/s40262-012-0022-9.
36. Laughon MM, Benjamin Jr DK, Capparelli EV, Kearns GL, Berezny K, Paul IM, et al. Innovative clinical trial design for pediatric therapeutics. Expert Rev Clin Pharmacol. 2011;4:643-52. doi: http://dx.doi.org/10.1586/ecp.11.43.
37. Morford LL, Bowman CJ, Blanset DL, Bogh IB, Chellman GJ, Halpern WG. Preclinical safety evaluations supporting pediatric drug development with biopharmaceuticals: strategy, challenges, current practices. Birth Defects Res B Dev Reprod Toxicol. 2011;92(4):359-80. doi: http://dx.doi.org/10.1002/bdrb.20305.
38. Offringa M, van der Lee H. Small sample approach, and statistical and epidemiological aspects. Handb Exp Pharmacol. 2011;205:181-202. doi: http://dx.doi.org/10.1007/978-3-642-20195-0_9.
39. Ogungbenro K, Matthews I, Looby M, Kaiser G, Graham G, Aarons L. Population pharmacokinetics and optimal design of paediatric studies for famciclovir. Br J Clin Pharmacol. 2009;68(4):546-60. doi: http://dx.doi.org/10.1111/j.1365-2125.2009.03479.x.
40. De Cock RF, Piana C, Krekels EH, Danhof M, Allegaert K, Knibbe CA. The role of population PK-PD modelling in paediatric clinical research. Eur J Clin Pharmacol. 2011;67 Suppl 1:5-16. doi: http://dx.doi.org/10.1007/s00228-009-0782-9.
41. Price J, Hindmarsh P, Hughes S, Effthimiou J. Evaluating the effects of asthma therapy on childhood growth: principles of study design. Eur Respir J. 2002;19(6):1167-78.
42. Bradley JS. Considerations unique to pediatrics for clinical trial design in hospital-acquired pneumonia and ventilator-associated pneumonia. Clin Infect Dis. 2010;51 Suppl 1:S136-43.
43. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med. 2010;7(2):e1000217.
44. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W-65-W-94.
45. Smith DC, Boel-Studt S, Cleeland L. Parental consent in adolescent substance abuse treatment outcome studies. J Subst Abuse Treat. 2009;37(3):298-306.
46. Network E. Enhancing the quality and transparency of health research. Accessed at www. equator-network.org on 15 September 2015;9.
47. Thomas J, Harden A. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med Res Methodol. 2008;8(1):45.
48. Rothenberger LG, Henschel AD, Schrey D, Becker A, Boos J. Methodological and ethical aspects of randomized controlled clinical trials in minors with malignant diseases.[Erratum appears in Pediatr Blood Cancer. 2012 July 15;59(1):205]. Pediatr Blood Cancer. 2011;57(4):599-605.
49. Clyburne-Sherin AT, Pravheen T, Chan WY, Offringa M. Recommendations and evidence for reporting items in pediatric clinical trial protocols and reports: two systematic reviews. 2014. http://hdl.handle.net/10864/10880
50. Vray M, Girault D, Hoog-Labouret N, Porcher R, Thalabard JC. Round Table Number GXIX. Methodology for small clinical trials. Therapie. 2004;59(3):273-9. 81-6.
51. Mwangoka G, Ogutu B, Msambichaka B, Mzee T, Salim N, Kafuruki S, et al. Experience and challenges from clinical trials with malaria vaccines in Africa. Malar J. 2013;12:86.
52. Carleer J, Karres J. Juvenile animal studies and pediatric drug development: a European regulatory perspective. Birth Defects Res B Dev Reprod Toxicol. 2011;92(4):254-60.
53. Hiremath GS, Omer SB. A meta-analysis of studies comparing the respiratory route with the subcutaneous route of measles vaccine administration. Hum Vaccin. 2005;1(1):30-6.
54. Reed C, Madhi SA, Klugman KP, Kuwanda L, Ortiz JR, Finelli L, et al. Development of the Respiratory Index of Severity in Children (RISC) score among young children with respiratory infections in South Africa. PLoS ONE [Electronic Resource]. 2012;7(1):e27793.
55. Coulibaly D, Diallo DA, Thera MA, Dicko A, Guindo AB, Kone AK, et al. Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. Am J Trop Med Hyg. 2002;67(6):604-10.
56. Toschke AM, Kohl L, Mansmann U, von Kries R. Meta-analysis of blood pressure tracking from childhood to adulthood and implications for the design of intervention trials. Acta Paediatr. 2010;99(1):24-9.
57. Claessen JQ, Appelman CL, Touw-Otten FW, De Melker RA, Hordijk GJ. A review of clinical trials regarding treatment of acute otitis media. Clin Otolaryngol Allied Sci. 1992;17(3):251-7.
58. Kasari C, Patterson S. Interventions addressing social impairment in autism. Curr Psychiatry Rep. 2012;14(6):713-25.
59. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47(7):1094-120.
60. Jacqz-Aigrain E. Drug policy in Europe Research and funding in neonates: current challenges, future perspectives, new opportunities. Early Hum Dev. 2011;87 Suppl 1:S27-30.
61. Spetie L, Arnold LE. Ethical issues in child psychopharmacology research and practice: emphasis on preschoolers. Psychopharmacology (Berl). 2007;191(1):15-26.
62. Gore SM. Statistical considerations in infant nutrition trials. Lipids. 1999;34(2):185-97.
63. Ramsey BW, Boat TF. Outcome measures for clinical trials in cystic fibrosis. Summary of a Cystic Fibrosis Foundation consensus conference. J Pediatr. 1994;124(2):177-92.
64. Cella M, Danhof M, Della PO. Adaptive trials in paediatric development: dealing with heterogeneity and uncertainty in pharmacokinetic differences in children. Br J Clin Pharmacol. 2012;74(2):346-53.
65. Cramer K, Wiebe N, Moyer V, Hartling L, Williams K, Swingler G, et al. Children in reviews: methodological issues in child-relevant evidence syntheses. BMC Pediatr. 2005;5:38.
66. Piana C, Kliphuis E, Della PO. Lack of compliance of European Public Assessment Reports to guidelines for paediatric drug development before the introduction of paediatric investigation plans. Clin Trials. 2013;10(2):269-79.
67. Mosley C, Whittle C, Hicks C. A pilot study to assess the viability of a randomised controlled trial of methods of supplementary feeding of breast-fed pre-term babies. Midwifery. 2001;17(2):150-7.
68. Dune LS, Shiao SY. Metaanalysis of acustimulation effects on postoperative nausea and vomiting in children. Explore: The Journal of Science & Healing. 2006;2(4):314-20.
69. Barua M, Hladunewich M, Keunen J, Pierratos A, McFarlane P, Sood M, et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol. 2008;3(2):392-6. doi: http://dx.doi.org/10.2215/CJN.04110907.
70. Kolevzon A, Mathewson KA, Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry. 2006;67(3):407-14.
71. Ghanizadeh A, Freeman RD, Berk M. Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD: a systematic review of non-controlled and controlled trials. Rev Recent Clin Trials. 2013;8(1):2-8.
72. Altavilla A. Ethical key issues and fundamental rights in paediatric research. Eur J Clin Pharmacol. 2011;67 Suppl 1:117-23.
73. Olver IN. The development of future research strategies from reviewing antiemetic trials for chemotherapy induced emesis. Rev Recent Clin Trials. 2006;1(1):61-6. doi: http://dx.doi.org/10.2174/157488706775246094.
74. Frank E, Novick DM, Kupfer DJ. Beyond the question of placebo controls: ethical issues in psychopharmacological drug studies. Psychopharmacology (Berl). 2003;171(1):19-26.
75. Campbell M, Rapoport JL, Simpson GM. Antipsychotics in children and adolescents. J Am Acad Child Adolesc Psychiatry. 1999;38(5):537-45.
76. Bagot KS, Heishman SJ, Moolchan ET. Tobacco craving predicts lapse to smoking among adolescent smokers in cessation treatment. Nicotine Tob Res. 2007;9(6):647-52.
77. Kan P, Kestle JR. Designing randomized clinical trials in pediatric neurosurgery. Childs Nervous System. 2007;23(4):385-90.
78. Cole M, Boddy AV, Kearns P, Teh KH, Price L, Parry A, et al. Potential clinical impact of taking multiple blood samples for research studies in paediatric oncology: how much do we really know? Pediatr Blood Cancer. 2006;46(7):723-7.
79. Franklin M, Foa E, March JS. The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods. J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S39-51.
80. Vitiello B. Research in child and adolescent psychopharmacology: recent accomplishments and new challenges. Psychopharmacology (Berl). 2007;191(1):5-13.
81. Knibbe CA, Krekels EH, Danhof M. Advances in paediatric pharmacokinetics. Expert Opin Drug Metab Toxicol. 2011;7(1):1-8.
82. Sharav VH. Children in clinical research: a conflict of moral values. Am J Bioethics. 2003;3(1):W-IF 2.
83. Voth M, Rosenberg M, Breuer J. Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance. Invest Radiol. 2011;46(11):663-71.
84. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin Infect Dis. 1992;15 Suppl 1:S216-27.
85. Paoletti X, Geoerger B, Doz F, Baruchel A, Lokiec F, Le Tourneau C. A comparative analysis of paediatric dose-finding trials of molecularly targeted agent with adults' trials. Eur J Cancer. 2013;49(10):2392-402.
86. Sammons H. Ethical issues of clinical trials in children: a European perspective. Arch Dis Child. 2009;94(6):474-7.
87. Ligi I, Boubred F, Grandvuillemin I, Simeoni U. Clinical research in newborn infants: difficulties and specificity. Eur J Clin Pharmacol. 2011;67 Suppl 1:29-32.
88. Ackerman TF. The ethics of drug research in children. Paediatr Drugs. 2001;3(1):29-41.
89. Sampson MR, Benjamin DK, Cohen-Wolkowiez M. Evidence-based guidelines for pediatric clinical trials: focus on StaR Child Health. Expert Rev Clin Pharmacol. 2012;5(5):525-31.
90. Hausner E, Fiszman ML, Hanig J, Harlow P, Zornberg G, Sobel S. Long-term consequences of drugs on the paediatric cardiovascular system. Drug Saf. 2008;31(12):1083-96.
91. MacDonald S, Rothwell H, Moore L. Getting it right: designing adolescent-centred smoking cessation services. Addiction. 2007;102(7):1147-50.
92. Colon CL, Ahearn WH, Clark KM, Masalsky J. The effects of verbal operant training and response interruption and redirection on appropriate and inappropriate vocalizations. J Appl Behav Anal. 2012;45(1):107-20.
93. Clemens J, Sack D, Rao M, Chakraborty J, Kay B, Ahmed F, et al. The design and analysis of cholera vaccine trials: recent lessons from Bangladesh. Int J Epidemiol. 1993;22(4):724-30.
94. Jefferson T, Price D, Demicheli V, Bianco E. European Research Program for Improved Vaccine Safety Surveillance Project. Unintended events following immunization with MMR: a systematic review. Vaccine. 2003;21(25-26):3954-60.
95. McDonagh MS, Osterweil P, Guise JM. The benefits and risks of inducing labour in patients with prior caesarean delivery: a systematic review. BJOG. 2005;112(8):1007-15.
96. O'Lonergan TA, Milgrom H. Ethical considerations in research involving children. Curr Allergy Asthma Rep. 2005;5(6):451-8.
97. Dunlop BW, Banja J. A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders. J Med Ethics. 2009;35(6):384-9.
98. Hartling L, Wittmeier KD, Caldwell PH, van der Lee JH, Klassen TP, Craig JC, et al. StaR Child Health: developing evidence-based guidance for the design, conduct, and reporting of pediatric trials. Clin Pharmacol Ther. 2011;90(5):727-31. doi: http://dx.doi.org/10.1038/clpt.2011.212.
99. Knellwolf AL, Bauzon S, Alberighi OD, Lutsar I, Bacsy E, Alfarez D, et al. Framework conditions facilitating paediatric clinical research. Ital J Pediatr. 2011;37:12.
100. Brendel DH, Miller FG. A plea for pragmatism in clinical research ethics. Am J Bioethics. 2008;8(4):24-31.
101. Lindsey JC, Shah SK, Siberry GK, Jean-Philippe P, Levin MJ. Ethical tradeoffs in trial design: case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings. Dev World Bioeth. 2013;13(2):95-104.
102. Barsevick AM, Irwin MR, Hinds P, Miller A, Berger A, Jacobsen P, et al. Recommendations for high-priority research on cancer-related fatigue in children and adults. J Natl Cancer Inst. 2013;105(19):1432-40.
103. Lande MB, Adams HR, Kupferman JC, Hooper SR, Szilagyi PG, Batisky DL. A multicenter study of neurocognition in children with hypertension: methods, challenges, and solutions. J Am Soc Hypertens. 2013;7(5):353-62.
104. Chitnis T, Tardieu M, Amato MP, Banwell B, Bar-Or A, Ghezzi A, et al. International Pediatric MS Study Group Clinical Trials Summit: meeting report. Neurology. 2013;80(12):1161-8. doi: http://dx.doi.org/10.1212/WNL.0b013e318288694e.
105. Carlson GA, Jensen PS, Findling RL, Meyer RE, Calabrese J, DelBello MP, et al. Methodological issues and controversies in clinical trials with child and adolescent patients with bipolar disorder: report of a consensus conference. J Child Adolesc Psychopharmacol. 2003;13(1):13-27.
106. Mitchell LG, Male C. Outcome measures in interventional trials for prevention or treatment of venous thrombosis in the pediatric population. Semin Thromb Hemost. 2011;37(7):840-7.
107. Sutherland ER, Busse WW, National Heart, Lung, and Blood Institute's AsthmaNet. Designing clinical trials to address the needs of childhood and adult asthma: the National Heart, Lung, and Blood Institute's AsthmaNet. J Allergy Clin Immunol. 2014;133(1):34-8. e1.
108. Jaspers MW, Caron H, Behrendt H, van den Bos C, Bakker P, Van Leeuwen F. The development of a new information model for a pediatric cancer registry on late treatment sequelae in The Netherlands. Stud Health Technol Inform. 2000;77:895-9.
109. Cliff DP, Reilly JJ, Okely AD. Methodological considerations in using accelerometers to assess habitual physical activity in children aged 0-5 years. J Sci Med Sport. 2009;12(5):557-67. doi: http://dx.doi.org/10.1016/j.jsams.2008.10.008.
110. Holgate ST, Bousquet J, Chung KF, Bisgaard H, Pauwels R, Fabbri L, et al. Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma. Respir Med. 2004;98(6):479-87.
111. Giaccone A, Jensen E, Davis P, Schmidt B. Definitions of extubation success in very premature infants: a systematic review. Arch Dis Child Fetal Neonatal Ed. 2014;99(2):F124-7.
112. Matza LS, Patrick DL, Riley AW, Alexander JJ, Rajmil L, Pleil AM, et al. Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force. Value Health. 2013;16(4):461-79.
113. Barrett A, Clark M, Demuro C, Esser D. Proxy-reported questionnaires for young children with asthma: a structured review. Eur Respir J. 2013;42(2):513-26.
114. Tsoi WS, Zhang LA, Wang WY, Tsang KL, Lo SK. Improving quality of life of children with cerebral palsy: a systematic review of clinical trials. Child Care Health Dev. 2012;38(1):21-31.
115. Varni JW, Limbers CA, Newman DA. Using factor analysis to confirm the validity of children's self-reported health-related quality of life across different modes of administration. Clin Trials. 2009;6(2):185-95.
116. Sun GH. Bibliometric analysis of health services research in otolaryngology journals. Otolaryngol Head Neck Surg. 2012;147(5):841-7. doi: http://dx.doi.org/10.1177/0194599812454405.
117. Sinha I, Jones L, Smyth RL, Williamson PR. A systematic review of studies that aim to determine which outcomes to measure in clinical trials in children. PLoS Medicine / Public Library of Science. 2008;5(4), e96.
118. Clausen J. Ethical brain stimulation - neuroethics of deep brain stimulation in research and clinical practice. Eur J Neurosci. 2010;32(7):1152-62.
119. Rustomjee R, McClain B, Brennan MJ, McLeod R, Chetty-Makkan CM, McShane H, et al. Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents. Tuberculosis. 2013;93(2):136-42.
120. Anderson M, Choonara I. A systematic review of safety monitoring and drug toxicity in published randomised controlled trials of antiepileptic drugs in children over a 10-year period. Arch Dis Child. 2010;95(9):731-8.
121. Degi A, Kerti A, Kis E, Cseprekal O, Tory K, Szabo AJ, et al. Cardiovascular risk assessment in children following kidney transplantation. Pediatr Transplant. 2012;16(6):564-76.
122. Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, et al. ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol. 2008;18(7):535-49.
123. Triolo RJ, Betz RR, Mulcahey MJ, Gardner ER. Application of functional neuromuscular stimulation to children with spinal cord injuries: candidate selection for upper and lower extremity research. Paraplegia. 1994;32(12):824-43.
124. Stice E, Marti CN, Spoor S, Presnell K, Shaw H. Dissonance and healthy weight eating disorder prevention programs: long-term effects from a randomized efficacy trial. J Consult Clin Psychol. 2008;76(2):329-40.
125. DiMichele DM. Ethical considerations in clinical investigation: exploring relevance in haemophilia research. Haemophilia. 2008;14 Suppl 3:122-9.
126. Hunfeld JA, Passchier J. Participation in medical research; a systematic review of the understanding and experience of children and adolescents. Patient Educ Couns. 2012;87(3):268-76.
127. Pedersen S, Szefler S. harmacological interventions. Childhood asthma. Eur Respir J Suppl. 1998;27:40s-5s.
128. Barlow J, Stewart-Brown S. Behavior problems and group-based parent education programs. J Dev Behav Pediatr. 2000;21(5):356-70.
129. Brennan L, Walkley J, Fraser SF, Greenway K, Wilks R. Motivational interviewing and cognitive behaviour therapy in the treatment of adolescent overweight and obesity: study design and methodology. Contemp Clin Trials. 2008;29(3):359-75.
130. Collins CE, Warren J, Neve M, McCoy P, Stokes BJ. Measuring effectiveness of dietetic interventions in child obesity: a systematic review of randomized trials. Arch Pediatr Adolesc Med. 2006;160(9):906-22.
131. Wirth MM, Scherer SM, Hoks RM, Abercrombie HC. The effect of cortisol on emotional responses depends on order of cortisol and placebo administration in a within-subject design. Psychoneuroendocrinology. 2011;36(7):945-54. doi: http://dx.doi.org/10.1016/j.psyneuen.2010.11.010.
132. Davidson AJ, O'Brien M. Ethics and medical research in children. Paediatr Anaesth. 2009;19(10):994-1004.
133. De Blieck EA, Augustine EF, Marshall FJ, Adams H, Cialone J, Dure L, et al. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates. Contemp Clin Trials. 2013;35(2):48-54. doi: http://dx.doi.org/10.1016/j.cct.2013.04.004.
134. Kauffman RE. Clinical trials in children: problems and pitfalls. Paediatr Drugs. 2000;2(6):411-8.
135. Shamoo AE, Moreno JD. Ethics of research involving mandatory drug testing of high school athletes in Oregon. Am J Bioethics. 2004;4(1):25-31.
136. Brown DM, Tammineni SK. Managing Sales of Beverages in Schools to Preserve Profits and Improve Children's Nutrition Intake in 15 Mississippi Schools. J Am Diet Assoc. 2009;109(12):2036-42. doi: http://dx.doi.org/10.1016/j.jada.2009.09.008.
137. Reif S, Schultze-Mosgau M, Sutter G. From adults to children: simulation-based choice of an appropriate sparse-sampling schedule. Paediatr Drugs. 2012;14(3):189-200.
138. Landais P, Daures JP. Clinical trials, immunosuppression and renal transplantation: new trends in design and analysis. Pediatr Nephrol. 2002;17(8):573-84.
139. Modi N. Risk management in neonatal research. Seminars In Fetal & Neonatal Medicine. 2005;10(1):99-104.
140. Chalmers I, Altman DG, McHaffie H, Owens N, Cooke RW. Data sharing among data monitoring committees and responsibilities to patients and science. Trials [Electronic Resource]. 2013;14:102.
141. Holubkov R, Casper TC, Dean JM, Anand KJ, Zimmerman J, Meert KL, et al. The role of the Data and Safety Monitoring Board in a clinical trial: the CRISIS study. Pediatr Crit Care Med. 2013;14(4):374-83.
142. Pandis N, Polychronopoulou A, Eliades T. An assessment of quality characteristics of randomised control trials published in dental journals. J Dent. 2010;38(9):713-21.
143. Hinshaw SP, Hoagwood K, Jensen PS, Kratochvil C, Bickman L, Clarke G, et al. AACAP 2001 research forum: challenges and recommendations regarding recruitment and retention of participants in research investigations. J Am Acad Child Adolesc Psy. 2004;43(8):1037-45.
144. Drotar D. Commentary: randomized controlled trials of psychological interventions with pediatric populations: the time has come and the Journal of Pediatric Psychology is ready. J Pediatr Psychol. 2005;30(5):409-12.
145. Schmitt HJ, Schuind A, Knuf M, Zepp F, Beutel K, von Konig CHW, et al. Acellular pertussis vaccines: the rationale for an efficacy trial in Germany. J Infect Dis. 1996;174 Suppl 3:S287-90.
146. de Melo-Martin I, Sondhi D, Crystal RG. When ethics constrains clinical research: trial design of control arms in "greater than minimal risk" pediatric trials. Hum Gene Ther. 2011;22(9):1121-7.
147. Garofalo E. Clinical development of antiepileptic drugs for children. Neurother. 2007;4(1):70-4.
148. Tait AR, Voepel-Lewis T, Malviya S. Presenting research information to children: a tale of two methods. Anesth Analg. 2007;105(2):358-64.
149. John H, Worek F, Thiermann H. LC-MS-based procedures for monitoring of toxic organophosphorus compounds and verification of pesticide and nerve agent poisoning. Anal Bioanal Chem. 2008;391(1):97-116. doi: http://dx.doi.org/10.1007/s00216-008-1925-z.
150. Chappuy H, Doz F, Blanche S, Gentet JC, Treluyer JM. Children's views on their involvement in clinical research. Pediatr Blood Cancer. 2008;50(5):1043-6.
151. Habers GE, Takken T. Safety and efficacy of exercise training in patients with an idiopathic inflammatory myopathy - -a systematic review. Rheumatology. 2011;50(11):2113-24.
152. Hoppu K. Patient recruitment - European perspective. Pediatrics. 1999;104(3 Pt 2):623-6.
153. Tait AR, Voepel-Lewis T, Zikmund-Fisher BJ, Fagerlin A. Presenting research risks and benefits to parents: does format matter? Anesth Analg. 2010;111(3):718-23.
154. Contopoulos-Ioannidis DG, Seto I, Hamm MP, Thomson D, Hartling L, Ioannidis JP, et al. Empirical evaluation of age groups and age-subgroup analyses in pediatric randomized trials and pediatric meta-analyses. Pediatrics. 2012;129 Suppl 3:S161-84.
155. Jonas WB, Anderson RL, Crawford CC, Lyons JS. A systematic review of the quality of homeopathic clinical trials. BMC Complement Altern Med. 2001;1:12.
156. Reynolds S, Wilson C, Austin J, Hooper L. Effects of psychotherapy for anxiety in children and adolescents: a meta-analytic review. Clin Psychol Rev. 2012;32(4):251-62.
157. Jaykaran G, Kantharia ND, Preeti Y, Bharddwaj P, Goyal J. Reporting statistics in clinical trials published in Indian journals: a survey. Afr Health Sci. 2010;10(2):204-7.
158. Drotar D. Shared dilemmas of research and practice in developmental and behavioral pediatrics: introduction to the special issue on methodology. J Dev Behav Pediatr. 1991;12(6):347-9.
159. Zhang B, Schmidt B. Do we measure the right end points? A systematic review of primary outcomes in recent neonatal randomized clinical trials. J Pediatr. 2001;138(1):76-80.
160. Kristman VL, Borg J, Godbolt AK, Salmi LR, Cancelliere C, Carroll LJ, et al. Methodological issues and research recommendations for prognosis after mild traumatic brain injury: results of the International Collaboration on Mild Traumatic Brain Injury Prognosis. Arch Phys Med Rehabil. 2014;95 Suppl 3:S265-77.
161. Cotton DJ, Powderly WG, Feinberg J, Abrams DI, Chaisson RE, Wheat LJ, et al. Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials Group. Clin Infect Dis. 1993;16:814-6.
162. Kleinman RE, Brown RT, Cutter GR, Dupaul GJ, Clydesdale FM. A research model for investigating the effects of artificial food colorings on children with ADHD. Pediatrics. 2011;127(6):e1575-84. doi: http://dx.doi.org/10.1542/peds.2009-2206.
163. Mann H. ASSERT: A Standard for the Scientific and Ethical Review of Trials. 2007. http://www.assert-statement.org/. 2014.
164. Merlo DF, Knudsen LE, Matusiewicz K, Niebroj L, Vahakangas KH. Ethics in studies on children and environmental health. J Med Ethics. 2007;33(7):408-13.
165. Henschel AD, Rothenberger LG, Boos J. Randomized clinical trials in children - ethical and methodological issues. Curr Pharm Des. 2010;16(22):2407-15.